Patient Name : Mrs.

PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM

Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 02:06PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 03:42PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF HAEMATOLOGY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

HEMOGRAM , WHOLE BLOOD EDTA
HAEMOGLOBIN 12.3 g/dL 12-15 Spectrophotometer
PCV 37.20 % 36-46 Electronic pulse &
Calculation
RBC COUNT 4.64 Million/cu.mm 3.8-4.8 Electrical Impedence
MCV 80.1 fL 83-101 Calculated
MCH 26.5 pg 27-32 Calculated
MCHC 33.1 g/dL 31.5-34.5 Calculated
R.D.W 15.7 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 8,660 cells/cu.mm 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 58.1 % 40-80 Electrical Impedance
LYMPHOCYTES 30.4 % 20-40 Electrical Impedance
EOSINOPHILS 6.2 % 1-6 Electrical Impedance
MONOCYTES 4.7 % 2-10 Electrical Impedance
BASOPHILS 0.6 % <1-2 Electrical Impedance
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 5031.46 Cells/cu.mm 2000-7000 Calculated
LYMPHOCYTES 2632.64 Cells/cu.mm 1000-3000 Calculated
EOSINOPHILS 536.92 Cells/cu.mm 20-500 Calculated
MONOCYTES 407.02 Cells/cu.mm 200-1000 Calculated
BASOPHILS 51.96 Cells/cu.mm 0-100 Calculated
Neutrophil lymphocyte ratio (NLR) 1.91 0.78- 3.53 Calculated
PLATELET COUNT 307000 cells/cu.mm 150000-410000 Electrical impedence
ERYTHROCYTE SEDIMENTATION 13 mm at the end 0-20 Modified Westergren
RATE (ESR) of 1 hour
PERIPHERAL SMEAR
RBC's Anisocytosis+, Microcytes+, Elliptocytes+
WBC's are normal in number and morphology
Platelets are Adequate
No hemoparasite seen.
Page 1 of 14

SIN No:KHA250102281
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 02:06PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 03:42PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF HAEMATOLOGY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Page 2 of 14

SIN No:KHA250102281
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 12:04PM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 04:47PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 07:25PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

GLUCOSE, FASTING , NAF PLASMA 87 mg/dL 70-100 HEXOKINASE

Comment:
As per American Diabetes Guidelines, 2023
Fasting Glucose Values in mg/dL Interpretation
70-100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes
<70 mg/dL Hypoglycemia
Note:
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2 hr post glucose value of
> or = 200 mg/dL on at least 2 occasions.
2. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered critical.

Test Name Result Unit Bio. Ref. Interval Method

GLUCOSE, POST PRANDIAL (PP), 2 103 mg/dL 70-140 HEXOKINASE
HOURS , SODIUM FLUORIDE PLASMA (2
HR)

Comment:
It is recommended that FBS and PPBS should be interpreted with respect to their Biological reference ranges and not with each
other.
Conditions which may lead to lower postprandial glucose levels as compared to fasting glucose levels may be due to reactive
hypoglycemia, dietary meal content, duration or timing of sampling after food digestion and absorption, medications such as insulin
preparations, sulfonylureas, amylin analogues, or conditions such as overproduction of insulin.

Page 3 of 14

SIN No:KHA250102385
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 02:06PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 04:28PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

HBA1C (GLYCATED HEMOGLOBIN) , WHOLE BLOOD EDTA
HBA1C, GLYCATED HEMOGLOBIN 5.9 % HPLC
ESTIMATED AVERAGE GLUCOSE 123 mg/dL Calculated
(eAG)
Comment:
Reference Range as per American Diabetes Association (ADA) 2023 Guidelines:
REFERENCE GROUP HBA1C %
NON DIABETIC <5.7
PREDIABETES 5.7 – 6.4
DIABETES ≥ 6.5
DIABETICS
EXCELLENT CONTROL 6–7
FAIR TO GOOD CONTROL 7–8
UNSATISFACTORY CONTROL 8 – 10
POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. HbA1C is recommended by American Diabetes Association for Diagnosing Diabetes and monitoring Glycemic
Control by American Diabetes Association guidelines 2023.
2. Trends in HbA1C values is a better indicator of Glycemic control than a single test.
3. Low HbA1C in Non-Diabetic patients are associated with Anemia (Iron Deficiency/Hemolytic), Liver Disorders, Chronic Kidney Disease. Clinical Correlation is
advised in interpretation of low Values.
4. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or decrease mean erythrocyte age. HbA1c may
not accurately reflect glycemic control when clinical conditions that affect erythrocyte survival are present.
5. In cases of Interference of Hemoglobin variants in HbA1C, alternative methods (Fructosamine) estimation is recommended for Glycemic Control
A: HbF >25%
B: Homozygous Hemoglobinopathy.
(Hb Electrophoresis is recommended method for detection of Hemoglobinopathy)

Page 4 of 14

SIN No:KHA250102279
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 03:11PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 05:10PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

LIPID PROFILE , SERUM
TOTAL CHOLESTEROL 183 mg/dL <200 CHO-POD
TRIGLYCERIDES 109 mg/dL <150 GPO-POD
HDL CHOLESTEROL 49 mg/dL 40-60 Enzymatic
Immunoinhibition
NON-HDL CHOLESTEROL 134 mg/dL <130 Calculated
LDL CHOLESTEROL 112.41 mg/dL <100 Calculated
VLDL CHOLESTEROL 21.73 mg/dL <30 Calculated
CHOL / HDL RATIO 3.75 0-4.97 Calculated
ATHEROGENIC INDEX (AIP) < 0.01 <0.11 Calculated

Comment:
Reference Interval as per National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report.

Desirable Borderline High High Very High

TOTAL CHOLESTEROL < 200 200 - 239 ≥ 240
TRIGLYCERIDES <150 150 - 199 200 - 499 ≥ 500
Optimal < 100
LDL 130 - 159 160 - 189 ≥ 190
Near Optimal 100-129
HDL ≥ 60
Optimal <130;
NON-HDL CHOLESTEROL 160-189 190-219 >220
Above Optimal 130-159

Page 5 of 14

SIN No:KHA250102278
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 03:11PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 05:10PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

LIVER FUNCTION TEST (LFT) WITH GGT , SERUM
BILIRUBIN, TOTAL 0.34 mg/dL 0.3–1.2 DPD
BILIRUBIN CONJUGATED (DIRECT) 0.04 mg/dL <0.2 DPD
BILIRUBIN (INDIRECT) 0.30 mg/dL 0.0-1.1 Dual Wavelength
ALANINE AMINOTRANSFERASE 12.44 U/L <35 IFCC
(ALT/SGPT)
ASPARTATE AMINOTRANSFERASE 14.8 U/L <35 IFCC
(AST/SGOT)
AST (SGOT) / ALT (SGPT) RATIO (DE 1.2 <1.15 Calculated
RITIS)
ALKALINE PHOSPHATASE 87.97 U/L 30-120 IFCC
PROTEIN, TOTAL 7.32 g/dL 6.6-8.3 Biuret
ALBUMIN 4.27 g/dL 3.5-5.2 BROMO CRESOL
GREEN
GLOBULIN 3.05 g/dL 2.0-3.5 Calculated
A/G RATIO 1.4 0.9-2.0 Calculated
GAMMA GLUTAMYL 25.77 U/L <38 IFCC
TRANSPEPTIDASE (GGT)
Comment:
LFT results reflect different aspects of the health of the liver, i.e., hepatocyte integrity (AST & ALT), synthesis and secretion of
bile (Bilirubin, ALP), cholestasis (ALP, GGT), protein synthesis (Albumin) Common patterns seen:
1. Hepatocellular Injury: *AST – Elevated levels can be seen. However, it is not specific to liver and can be raised in cardiac and
skeletal injuries.*ALT – Elevated levels indicate hepatocellular damage. It is considered to be most specific lab test for
hepatocellular injury. Values also correlate well with increasing BMI. Disproportionate increase in AST, ALT compared with
ALP. AST: ALT (ratio) – In case of hepatocellular injury AST: ALT > 1In Alcoholic Liver Disease AST: ALT usually >2. This
ratio is also seen to be increased in NAFLD, Wilsons’s diseases, Cirrhosis, but the increase is usually not >2.Note- If both SGPT
and SGOT are within reference range then AST:ALT (De Ritis ratio) does not have any clinical significance.
2. Cholestatic Pattern:*ALP – Disproportionate increase in ALP compared with AST, ALT. ALP elevation also seen in
pregnancy, impacted by age and sex.*Bilirubin elevated- predominantly direct , To establish the hepatic origin correlation with
elevated GGT helps.
3. Synthetic function impairment:*Albumin- Liver disease reduces albumin levels, Correlation with PT (Prothrombin Time) helps.
Page 6 of 14

SIN No:KHA250102278
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 03:11PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 05:10PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

4. Associated tests for assessment of liver fibrosis - Fibrosis-4 and APRI Index.

Page 7 of 14

SIN No:KHA250102278
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 03:11PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 05:10PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

UREA. , SERUM 19.34 mg/dL 17-43 GLDH, Kinetic Assay
BLOOD UREA NITROGEN , SERUM 9.0 mg/dL 8.0 - 23.0 Calculated

Page 8 of 14

SIN No:KHA250102278
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 03:11PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 05:10PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF BIOCHEMISTRY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

CALCIUM , SERUM 10.09 mg/dL 8.8-10.6 Arsenazo III

Comments:-
Serum calcium measurements are done to monitor and diagnose disorders of skeletal system, parathyroid gland, kidney, muscular
disorders, and abnormal vitamin D and protein levels.

Test Name Result Unit Bio. Ref. Interval Method

CREATININE , SERUM 0.49 mg/dL 0.55-1.02 Modified Jaffe, Kinetic
.eGFR - ESTIMATED GLOMERULAR 125.80 mL/min/1.73m² >60 CKD-EPI FORMULA
FILTRATION RATE , SERUM

Test Name Result Unit Bio. Ref. Interval Method

URIC ACID , SERUM 4.57 mg/dL 2.6-6.0 Uricase PAP

Comments:-
Uric acid is an end product of purine catabolism. Most uric acid is synthesised in the liver & from the intestine.Two thirds of uric
acid is excreted by the kidneys.

Page 9 of 14

SIN No:KHA250102278
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 01:55PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 02:42PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF IMMUNOLOGY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

THYROID PROFILE TOTAL (T3, T4, TSH) , SERUM
TRI-IODOTHYRONINE (T3, TOTAL) 1.34 ng/mL 0.87-1.78 CLIA
THYROXINE (T4, TOTAL) 8.22 µg/dL 5.48-14.28
THYROID STIMULATING HORMONE 1.877 µIU/mL 0.38-5.33 CLIA
(TSH)

Comment:
For pregnant females Bio Ref Range for TSH in uIU/ml (As per American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0
1. TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH activates production of T3 (Triiodothyronine) and its prohormone T4 (Thyroxine). Increased
blood level of T3 and T4 inhibit production of TSH.
2. TSH is elevated in primary hypothyroidism and will be low in primary hyperthyroidism. Elevated or low TSH in the context of normal free thyroxine is often referred
to as sub-clinical hypo- or hyperthyroidism respectively.
3. Both T4 & T3 provides limited clinical information as both are highly bound to proteins in circulation and reflects mostly inactive hormone. Only a very small
fraction of circulating hormone is free and biologically active.
4. Significant variations in TSH can occur with circadian rhythm, hormonal status, stress, sleep deprivation, medication & circulating antibodies.
TSH T3 T4 FT4 Conditions
High Low Low Low Primary Hypothyroidism, Post Thyroidectomy, Chronic Autoimmune Thyroiditis

High N N N Subclinical Hypothyroidism, Autoimmune Thyroiditis, Insufficient Hormone Treatment.

N/Low Low Low Low Secondary and Tertiary Hypothyroidism

Low High High High Primary Hyperthyroidism, Goitre, Thyroiditis, Drug effects, Early Pregnancy
Low N N N Subclinical Hyperthyroidism
Low Low Low Low Central Hypothyroidism, Treatment with Hyperthyroidism
Low N High High Thyroiditis, Interfering Antibodies
N/Low High N N T3 Thyrotoxicosis, Non thyroidal causes
High High High High Pituitary Adenoma; TSHoma/Thyrotropinoma

Page 10 of 14

SIN No:KHA250102277
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 01:55PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 02:42PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF IMMUNOLOGY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

VITAMIN D (25 - OH VITAMIN D) , 33.79 ng/mL CLIA
SERUM

Comment:
BIOLOGICAL REFERENCE RANGES
VITAMIN D STATUS VITAMIN D 25 HYDROXY (ng/mL)
DEFICIENCY <10
INSUFFICIENCY 10 – 30
SUFFICIENCY 30 – 100
TOXICITY >100

The biological function of Vitamin D is to maintain normal levels of calcium and phosphorus absorption. 25-Hydroxy vitamin D is
the storage form of vitamin D. Vitamin D assists in maintaining bone health by facilitating calcium absorption. Vitamin D deficiency
can also cause osteomalacia, which frequently affects elderly patients.
Vitamin D Total levels are composed of two components namely 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 both of
which are converted into active forms. Vitamin D2 level corresponds with the exogenous dietary intake of Vitamin D rich foods as
well as supplements. Vitamin D3 level corresponds with endogenous production as well as exogenous diet and supplements.
Vitamin D from sunshine on the skin or from dietary intake is converted predominantly by the liver into 25-hydroxy vitamin D,
which has a long half-life and is stored in the adipose tissue. The metabolically active form of vitamin D, 1,25-di-hydroxy vitamin
D, which has a short life, is then synthesized in the kidney as needed from circulating 25-hydroxy vitamin D. The reference interval
of greater than 30 ng/mL is a target value established by the Endocrine Society.
Decreased Levels:- Inadequate exposure to sunlight, Dietary deficiency, Vitamin D malabsorption, Severe Hepatocellular
disease., Drugs like Anticonvulsants, Nephrotic syndrome.
Increased levels:- Vitamin D intoxication.

Test Name Result Unit Bio. Ref. Interval Method

VITAMIN B12 , SERUM 594 pg/mL 120-914 CLIA

Comment:
Population based data reflecting exact scenario of vitamin B12 levels in Indian population is still evolving, however, different studies
Page 11 of 14

SIN No:KHA250102277
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 01:55PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 02:42PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF IMMUNOLOGY
SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

reporting a deficiency in adults, pregnant women and children ranging from 16% to 77% with average of about 47%. This high
incidence is attributed to vegetarian food habits of large majority of Indian population.
Vitamin B12 deficiency frequently causes macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss
of proprioception, poor coordination, and affective behavioral changes. A significant increase in RBC MCV may be an important
indicator of vitamin B12 deficiency. B12 levels in the range of 150 to 190 pg/ml may not be associated with any clinical
manifestations, while B12 levels below 100 pg/ml are often associated with clinical symptoms. However, for an individual based on
other co-morbid conditions or other nutritional deficiency (especially folate) the manifestations can vary accordingly.
If clinical symptoms suggest deficiency, measurement of active vitamin B12, MMA and homocysteine should be considered as
further workup.

Page 12 of 14

SIN No:KHA250102277
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 04:57PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 06:01PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF CLINICAL PATHOLOGY

SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

Test Name Result Unit Bio. Ref. Interval Method

COMPLETE URINE EXAMINATION (CUE) , URINE
PHYSICAL EXAMINATION
COLOUR PALE YELLOW PALE YELLOW Scattering of light
TRANSPARENCY CLEAR CLEAR Scattering of light
pH 5.5 5-7.5 Bromothymol Blue
SP. GRAVITY 1.007 1.002-1.030 Bromothymol Blue
BIOCHEMICAL EXAMINATION
URINE PROTEIN NEGATIVE NEGATIVE PROTEIN ERROR OF
INDICATOR
GLUCOSE NORMAL NEGATIVE GOD-POD
URINE BILIRUBIN NEGATIVE NEGATIVE Diazonium Salt
URINE KETONES (RANDOM) NEGATIVE NEGATIVE Sodium nitro prusside
UROBILINOGEN NORMAL NORMAL (0.1- Diazonium salt
1.8mg/dl)
NITRITE NEGATIVE NEGATIVE Sulfanilic acid
LEUCOCYTE ESTERASE NEGATIVE NEGATIVE Diazonium salt
CENTRIFUGED SEDIMENT WET MOUNT AND MICROSCOPY
PUS CELLS 1-2 /hpf 0-5 Automated Image
based microscopy
EPITHELIAL CELLS 0-1 /hpf < 10 Automated Image
based microscopy
RBC 0 /hpf 0-2 Automated Image
based microscopy
CASTS NEGATIVE /lpf 0-2 Hyaline Cast Automated Image
based microscopy
CRYSTALS NEGATIVE /hpf Occasional-Few Automated Image
based microscopy

Comment:
All urine samples are checked for adequacy and suitability before examination. All abnormal chemical examination are rechecked
and verified by manual methods. Microscopy findings are reported as an average of 10 high power fields.

Page 13 of 14

SIN No:KHA250102282
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 04:57PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 06:01PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

DEPARTMENT OF CLINICAL PATHOLOGY

SVASTH LIFE AMAZON- 19A04-03 HEALTHI WITH 2D ECHO - PAN INDIA - FY 2425

*** End Of Report ***

Page 14 of 14

SIN No:KHA250102282
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
 Patient Name : Mrs.PRIYANKA DHANOTIA Collected : 18/Jan/2025 09:42AM
Age/Gender : 35 Y 5 M 13 D/F Received : 18/Jan/2025 04:57PM
UHID/MR No : CKHA.0000078760 Reported : 18/Jan/2025 06:01PM
Visit ID : CKHAOPV127527 Status : Final Report
Ref Doctor : Self Sponsor Name : SVASTH LIFE PRIVATE LIMITED
Emp/Auth/TPA ID : 900374

TERMS AND CONDITIONS GOVERNING THIS REPORT

1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.

SIN No:KHA250102282
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab